Apollomics APLM
NASDAQ APLM
$24.33 +0.76 (+3.21%)
As of: Aug 21, 2026 · 3:19 PM EDT

Apollomics (APLM) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2023)

Apollomics (APLM) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 24.71%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.77%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -99.85%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -5.07%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.70%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 10.87%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 70.79%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 19.14%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Apollomics 35.18 Mn 31.90 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -39.12%
Dec 31, 2022 65.42%
Dec 31, 2021 9.78%